SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 81 filers reported holding SPERO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,370 | -69.0% | 34,190 | -62.8% | 0.00% | – |
| Q2 2023 | $133,357 | +5.6% | 91,970 | +5.6% | 0.00% | – |
| Q1 2023 | $126,301 | +1171.7% | 87,104 | +1417.2% | 0.00% | – |
| Q4 2022 | $9,932 | -91.0% | 5,741 | -89.6% | 0.00% | – |
| Q3 2022 | $110,000 | +511.1% | 55,100 | +127.3% | 0.00% | – |
| Q2 2022 | $18,000 | -64.7% | 24,244 | +433.1% | 0.00% | – |
| Q3 2020 | $51,000 | +24.4% | 4,548 | +49.2% | 0.00% | – |
| Q2 2020 | $41,000 | +4000.0% | 3,048 | +2948.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,376,968 | $17,639,000 | 16.57% |
| Aquilo Capital Management, LLC | 1,054,356 | $13,506,000 | 5.98% |
| VHCP Management II, LLC | 474,015 | $6,072,000 | 1.78% |
| AWM Investment Company, Inc. | 562,296 | $7,203,000 | 1.42% |
| Alphabet Inc. | 1,112,473 | $14,251,000 | 0.74% |
| BVF INC/IL | 460,706 | $5,902,000 | 0.66% |
| DAFNA Capital Management LLC | 70,000 | $897,000 | 0.39% |
| Artal Group S.A. | 600,000 | $7,686,000 | 0.31% |
| Rock Springs Capital Management LP | 525,000 | $6,725,000 | 0.26% |
| Orbimed Advisors | 507,471 | $6,501,000 | 0.10% |